Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 4
2019 5
2020 3
2021 5
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.
Lucendo AJ, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-Infante J, Hartmann D, Bredenoord AJ, Ciriza de Los Rios C, Schubert S, Brückner S, Madisch A, Hayat J, Tack J, Attwood S, Mueller R, Greinwald R, Schoepfer A, Straumann A; International EOS-1 Study Group. Lucendo AJ, et al. Gastroenterology. 2019 Jul;157(1):74-86.e15. doi: 10.1053/j.gastro.2019.03.025. Epub 2019 Mar 26. Gastroenterology. 2019. PMID: 30922997 Free article. Clinical Trial.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Zeng Q, Klein C, Caruso S, Maille P, Allende DS, Mínguez B, Iavarone M, Ningarhari M, Casadei-Gardini A, Pedica F, Rimini M, Perbellini R, Boulagnon-Rombi C, Heurgué A, Maggioni M, Rela M, Vij M, Baulande S, Legoix P, Lameiras S; HCC-AI study group; Bruges L, Gnemmi V, Nault JC, Campani C, Rhee H, Park YN, Iñarrairaegui M, Garcia-Porrero G, Argemi J, Sangro B, D'Alessio A, Scheiner B, Pinato DJ, Pinter M, Paradis V, Beaufrère A, Peter S, Rimassa L, Di Tommaso L, Vogel A, Michalak S, Boursier J, Loménie N, Ziol M, Calderaro J. Zeng Q, et al. Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8. Lancet Oncol. 2023. PMID: 37951222
Ulcerative colitis induced by obinutuzumab in a patient treated for a folicular lymphoma.
López-Mourelle A, Rubiera M, Lamas-Álvarez S, Argüelles-Estrada P, de Francisco R, Pérez-Martínez I, Castaño-García A, Riestra S. López-Mourelle A, et al. Among authors: castano garcia a. Rev Esp Enferm Dig. 2023 Oct 26. doi: 10.17235/reed.2023.10009/2023. Online ahead of print. Rev Esp Enferm Dig. 2023. PMID: 37882200 Free article.
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.
Calafat M, Torres P, Tosca-Cuquerella J, Sánchez-Aldehuelo R, Rivero M, Iborra M, González-Vivo M, Vera I, de Castro L, Bujanda L, Barreiro-de Acosta M, González-Muñoza C, Calvet X, Benítez JM, Llorente-Barrio M, Surís G, Cañete F, Arias-García L, Monfort D, Castaño-García A, Garcia-Alonso FJ, Huguet JM, Marín-Jímenez I, Lorente R, Martín-Cardona A, Ferrer JÁ, Camo P, Gisbert JP, Pajares R, Gomollón F, Castro-Poceiro J, Morales-Alvarado J, Llaó J, Rodríguez A, Rodríguez C, Pérez-Galindo P, Navarro M, Jiménez-García N, Carrillo-Palau M, Blázquez-Gómez I, Sesé E, Almela P, Ramírez de la Piscina P, Taxonera C, Rodríguez-Lago I, Cabrinety L, Vela M, Mínguez M, Mesonero F, García MJ, Aguas M, Márquez L, Silva Porto M, Pineda JR, García-Etxebarría K, Bertoletti F, Brunet E, Mañosa M, Domènech E. Calafat M, et al. Among authors: castano garcia a. Therap Adv Gastroenterol. 2024 Jan 5;17:17562848231221713. doi: 10.1177/17562848231221713. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38187926 Free PMC article.
Crohn's disease induced by ocrelizumab in a patient with multiple sclerosis.
Carballo-Folgoso L, Celada-Sendino M, Castaño-García A, Oliva Nacarino P, Morales Del Burgo P, Pérez-Martínez I, de Francisco R, Riestra S. Carballo-Folgoso L, et al. Among authors: castano garcia a. Rev Esp Enferm Dig. 2022 Dec;114(12):766-767. doi: 10.17235/reed.2022.9152/2022. Rev Esp Enferm Dig. 2022. PMID: 36177822 Free article.
Low applicability of the ''Six-and-twelve score" in hepatocellular carcinoma treated with Drug-Eluting Beads Transarterial Chemoembolization.
Pipa-Muñiz M, Castaño-García A, Sanmartino S, Mesa A, Álvarez-Navascués C, González-Diéguez ML, Cadahía-Rodrigo V, Piscoya-Díaz ME, Costilla-García SM, Rodríguez M, Varela M. Pipa-Muñiz M, et al. Among authors: castano garcia a. Rev Esp Enferm Dig. 2022 Jan;114(1):28-34. doi: 10.17235/reed.2021.7696/2020. Rev Esp Enferm Dig. 2022. PMID: 33733800 Free article.
Characteristics and consequences of missed gastric cancer: A multicentric cohort study.
Hernanz N, Rodríguez de Santiago E, Marcos Prieto HM, Jorge Turrión MÁ, Barreiro Alonso E, Rodríguez Escaja C, Jiménez Jurado A, Sierra M, Pérez Valle I, Volpato N, García Prada M, Nuñez-Gómez L, Ríos-León R, Castaño García A, García de Paredes AG, Aicart M, Caminoa A, Peñas Parcía B, Vázquez-Sequeiros E, Albillos A. Hernanz N, et al. Among authors: castano garcia a. Dig Liver Dis. 2019 Jun;51(6):894-900. doi: 10.1016/j.dld.2019.02.006. Epub 2019 Feb 26. Dig Liver Dis. 2019. PMID: 30898522
23 results